Exhibit 23.1
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT
We consent to the incorporation by reference in this Registration Statement of Viking Therapeutics, Inc. on Form S-8 of our report, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, dated March 8, 2016, with respect to our audits of the financial statements of Viking Therapeutics, Inc. as of December 31, 2015 and 2014 and for the years then ended, appearing in the Annual Report on Form 10-K of Viking Therapeutics, Inc. for the year ended December 31, 2015.
/s/ Marcum LLP
Marcum LLP
Irvine, California
May 10, 2016
